Impact of the dark zone signature on CNS relapse
Central nervous system (CNS) relapse in diffuse large B-cell lymphoma is associated with poor outcomes necessitating the identification of high-risk patients. To refine CNS risk stratification, a better understanding of the role of molecular risk factors is required. Dr. Waleed Alduaij, hematologist at BC Cancer in Vancouver, CA analysed the impact of the dark zone signature on CNS relapse in a real-world diffuse large B-cell lymphoma population.
With the educational support of:
